Search

Search Constraints

You searched for: Author/Creator Grossi, Laurino

Search Results

2. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. Issue 10 (12th January 2020)

3. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. Issue 10 (December 2020)

4. An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors. (13th August 2022)

5. An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors. (13th August 2022)

6. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study. Issue 1 (12th May 2022)

7. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. (3rd March 2016)

8. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Issue 7 (30th April 2020)

9. Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third‐Line Treatment of Helicobacter pylori Infection: Two Pilot Studies. Issue 5 (25th January 2016)

10. Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey. Issue 11 (8th October 2020)